Tripeptide-29

Tripeptide-29 (INCI name: Glycyl Prolyl Hydroxyproline; sequence: Gly-Pro-Hyp) is the most abundant tripeptide repeat unit found in the collagen molecule. Type I collagen - the primary structural protein of skin, tendons, bone, and most connective tissues - is characterised by a repeating Gly-X-Y tripeptide sequence, where X is frequently proline and Y is frequently hydroxyproline. The specific Gly-Pro-Hyp combination constitutes approximately one-third of all collagen residues and is uniquely responsible for the stability of the collagen triple helix through hydrogen bonding and the conformational constraints imposed by pyrrolidine ring-containing amino acids.

The discovery that ingested collagen hydrolysates can stimulate skin collagen synthesis led to research identifying which specific peptides within collagen hydrolysates are biologically active. Tripeptide-29 (Gly-Pro-Hyp) was identified as one of the primary bioactive components of collagen hydrolysates that is absorbed from the gastrointestinal tract into the bloodstream and reaches skin fibroblasts. When fibroblasts encounter this tripeptide, they respond by increasing collagen synthesis - a signal that is interpreted as indicating collagen breakdown (since Gly-Pro-Hyp is released when collagen is degraded) and triggering replacement synthesis.

The stability-promoting role of Tripeptide-29 within the collagen triple helix itself has been studied biophysically. The hydroxyl group on hydroxyproline forms stereoelectronic effects that lock the pyrrolidine ring into a specific conformation, pre-organising the Gly-Pro-Hyp residues into the geometry required for triple helix formation. This conformational pre-organisation lowers the entropic cost of triple helix assembly, significantly stabilising the collagen structure. Experimental evidence shows that Tripeptide-29's presence in collagen reduces UV-radiation-induced degradation and thermal denaturation.

Glycation damage is a major contributor to skin aging. When skin collagen is glycated by glucose and other sugars, the resulting advanced glycation end products (AGEs) cross-link collagen fibres, making them stiff, yellow, and resistant to normal turnover. Studies on hydrolysed collagen containing Tripeptide-29 have demonstrated reduction in AGE accumulation and the oxidative stress associated with glycation - suggesting that Tripeptide-29 may protect collagen from this aging mechanism.